ILYANG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,710 KRW | +0.22% |
|
-1.01% | -12.40% |
| Sales 2022 | 384B 279M 381M | Sales 2023 | 371B 269M 368M | Capitalization | 281B 204M 279M |
|---|---|---|---|---|---|
| Net income 2022 | 19.24B 13.99M 19.1M | Net income 2023 | -2.55B -1.85M -2.53M | EV / Sales 2022 | 0.97 x |
| Net Debt 2022 | 20.7B 15.05M 20.55M | Net Debt 2023 | 65.35B 47.51M 64.89M | EV / Sales 2023 | 0.94 x |
| P/E ratio 2022 |
18.7
x | P/E ratio 2023 |
-112
x | Employees | 655 |
| Yield 2022 |
0.78% | Yield 2023 |
0.96% | Free-Float | 66.03% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.22% | ||
| 1 week | -1.01% | ||
| Current month | -4.33% | ||
| 1 month | -7.05% | ||
| 3 months | -4.79% | ||
| 6 months | +2.24% | ||
| Current year | -12.40% |
1 week
13 640.00
14 050.00
1 month
13 640.0014 850.00
Current year
13 640.0016 080.00
1 year
13 130.0018 100.00
3 years
13 130.0042 400.00
5 years
13 130.00106 500.00
10 years
13 130.00106 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Yeon Kim
CEO | Chief Executive Officer | 73 | - |
Yoo-Seok Chung
CEO | Chief Executive Officer | 47 | - |
Gyoo-Young Choi
BRD | Director/Board Member | 66 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yoo-Seok Chung
CEO | Chief Executive Officer | 47 | - |
Dong-Yeon Kim
CEO | Chief Executive Officer | 73 | - |
Gyoo-Young Choi
BRD | Director/Board Member | 66 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 13,710 | +0.22% | 16,079 |
| 24-04-25 | 13,680 | -1.37% | 37,803 |
| 24-04-24 | 13,870 | -0.29% | 49,880 |
| 24-04-23 | 13,910 | +0.36% | 9,199 |
| 24-04-22 | 13,860 | +0.07% | 17,834 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
Ilyang Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company mainly manufactures and sells pharmaceutical products including prostatitis agents, anti-inflammatory drugs, diabetic agents, gastritis agents, and others. The Company also produces products including nourishing tonics and health supplements, among others.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.40% | 179M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- A007570 Stock
